ANTI ATHEROGENIC

/ SCIENCE, SOLUTIONS / By
  1. The anti-carcinogenic and ANTI-ATHEROGENIC effects of lycopene: a review
  2. The metabolism and ANTI-ATHEROGENIC properties of HDL
  3. The anti-inflammatory and potential ANTI-ATHEROGENIC effect of insulin: a new paradigm
  4. Anti-inflammatory and ANTI-ATHEROGENIC properties of adiponectin
  5. ANTI-ATHEROGENIC effects of resveratrol
  6. The forgotten face of regular physical exercise: a ‘natural’ANTI-ATHEROGENIC activity
  7. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an ANTI-ATHEROGENIC mediator?
  8. Interferon-γ and atherosclerosis: pro-or ANTI-ATHEROGENIC?
  9. Thiazolidinediones as anti‐inflammatory and anti‐atherogenic agents
  10. Protein composition determines the ANTI-ATHEROGENIC properties of HDL in transgenic mice
  11. Resveratrol and ANTI-ATHEROGENIC effects
  12. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an ANTI-ATHEROGENIC lipid profile
  13. ANTI-ATHEROGENIC effects of seabuckthorn (Hippophaea rhamnoides) seed oil
  14. Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and ANTI-ATHEROGENIC adipokine
  15. Nuts: ANTI-ATHEROGENIC food?
  16. ANTI-ATHEROGENIC mechanisms of high density lipoprotein: effects on myeloid cells
  17. ANTI-ATHEROGENIC and anti-angiogenic activities of polyphenols from propolis
  18. Evaluation of antioxidant and ANTI-ATHEROGENIC properties of Glycyrrhiza glabra root using in vitro models
  19. Advanced glycation of apolipoprotein AI impairs its ANTI-ATHEROGENIC properties
  20. Insights into the molecular mechanisms of the ANTI-ATHEROGENIC actions of flavonoids in normal and obese mice
  21. ANTI-ATHEROGENIC effect of coenzyme Q10 in apolipoprotein E gene knockout mice
  22. Heme oxygenase–carbon monoxide signalling pathway in atherosclerosis: ANTI-ATHEROGENIC actions of bilirubin and carbon monoxide?
  23. Antioxidant and ANTI-ATHEROGENIC activities of olive oil phenolics
  24. Natural compounds as ANTI-ATHEROGENIC agents: Clinical evidence for improved cardiovascular outcomes
  25. Antioxidant and ANTI-ATHEROGENIC activities of three Piper species on atherogenic diet fed hamsters
  26. Anti-inflammatory and ANTI-ATHEROGENIC effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice
  27. Evaluation of the ANTI-ATHEROGENIC potential of chrysin in Wistar rats
  28. The hyperpolarizing impact of glycine on endothelial cells may be ANTI-ATHEROGENIC
  29. Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and ANTI-ATHEROGENIC activity
  30. Possible anti‐atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats
  31. Eicosapentaenoic acid-enriched high-density lipoproteins exhibit ANTI-ATHEROGENIC properties
  32. Cardioprotective effects of high-density lipoprotein beyond its ANTI-ATHEROGENIC action
  33. ANTI-ATHEROGENIC and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus
  34. ANTI-ATHEROGENIC effects of 17β-estradiol
  35. ANTI-ATHEROGENIC effect of nuts: is the answer NO?
  36. An ANTI-ATHEROGENIC effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol
  37. Naringenin derivatives as ANTI-ATHEROGENIC agents
  38. Apolipoprotein mimetic peptides: Mechanisms of action as ANTI-ATHEROGENIC agents
  39. Sphingosine 1-phosphate induced ANTI-ATHEROGENIC and atheroprotective M2 macrophage polarization through IL-4
  40. ANTI-ATHEROGENIC Effect of Laminar Shear Stress via Nrf2 Activation
  41. Regulation of pro-and ANTI-ATHEROGENIC cytokines
  42. Neuronal nitric oxide synthase as a novel ANTI-ATHEROGENIC factor
  43. ANTI-ATHEROGENIC effect of insulin in vivo
  44. Phenolic compounds and the ANTI-ATHEROGENIC effect of bee bread in high-fat diet-induced obese rats
  45. ANTI-ATHEROGENIC effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits
  46. A study of anti-hyperlipidemia, hypolipedimic and ANTI-ATHEROGENIC activity of fruit of Emblica officinalis (amla) in high fat fed albino rats
  47. ANTI-ATHEROGENIC properties of date vs. pomegranate polyphenols: the benefits of the combination
  48. ANTI-ATHEROGENIC effects of orlistat on obesity-induced vascular oxidative stress rat model
  49. Phytosterol supplementation could improve atherogenic and ANTI-ATHEROGENIC apolipoproteins: a systematic review and dose–response meta-analysis of randomized …
  50. Apolipoprotein AI mimetic peptide helix number and helix linker influence potentially ANTI-ATHEROGENIC properties
  51. Placental secretion of apolipoprotein A1 and E: the ANTI-ATHEROGENIC impact of the placenta
  52. An experimental evaluation of the ANTI-ATHEROGENIC potential of the plant, Piper betle, and its active constitutent, eugenol, in rats fed an atherogenic diet
  53. ANTI-ATHEROGENIC activity of ethanolic fraction of Terminalia arjuna bark on hypercholesterolemic rabbits
  54. Atherogenic and ANTI-ATHEROGENIC factors in the human diet
  55. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: ANTI-ATHEROGENIC role for paraoxonase-2
  56. Anti‐atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase‐1
  57. ANTI-ATHEROGENIC potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
  58. Resveratrol mediates ANTI-ATHEROGENIC effects on cholesterol flux in human macrophages and endothelium via PPARγ and adenosine
  59. Nitric oxide enhances the anti-inflammatory and ANTI-ATHEROGENIC activity of atorvastatin in a mouse model of accelerated atherosclerosis
  60. Anti‐Atherogenic Effect of Stem Cell Nanovesicles Targeting Disturbed Flow Sites
  61. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential ANTI-ATHEROGENIC function?
  62. Glucose lowering and ANTI-ATHEROGENIC effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors
  63. Anti-oxidant and ANTI-ATHEROGENIC properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice
  64. Role of sphingosine 1-phosphate in ANTI-ATHEROGENIC actions of high-density lipoprotein
  65. Altered activities of ANTI-ATHEROGENIC enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
  66. ANTI-ATHEROGENIC effects of the methanol extract of Sorbus cortex in atherogenic-diet rats
  67. Anti‐atherogenic effect of berberine on LXRα‐ABCA1‐dependent cholesterol efflux in macrophages
  68. AMPK activation enhances the ANTI-ATHEROGENIC effects of high density lipoproteins in apoE−/− mice
  69. … (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and ANTI-ATHEROGENIC effects
  70. Taurine supplementation has ANTI-ATHEROGENIC and anti-inflammatory effects before and after incremental exercise in heart failure
  71. Structural evidence of ANTI-ATHEROGENIC microRNAs
  72. Inhibition of cytokine-induced vascular cell adhesion molecule-1 expression; possible mechanism for ANTI-ATHEROGENIC effect of Agastache rugosa
  73. Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in …
  74. A review of the cardiovascular and ANTI-ATHEROGENIC effects of ghrelin
  75. ANTI-ATHEROGENIC property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: comparison with clofibrate
  76. Aminoguanidine has an ANTI-ATHEROGENIC effect in the cholesterol-fed rabbit
  77. Evaluation of the in vitro ANTI-ATHEROGENIC activities of goat milk and goat dairy products
  78. In silico design of ANTI-ATHEROGENIC biomaterials
  79. ANTI-ATHEROGENIC activity of polyphenol-rich extract from bee pollen
  80. Regulation of ANTI-ATHEROGENIC apolipoprotein M gene expression by the orphan nuclear receptor LRH-1
  81. Vitamin E: the evidence for an ANTI-ATHEROGENIC role.
  82. ANTI-ATHEROGENIC effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene
  83. Overexpression of STARD3 in human monocyte/macrophages induces an ANTI-ATHEROGENIC lipid phenotype
  84. In vitro ANTI-ATHEROGENIC properties of traditional Greek cheese lipid fractions
  85. ANTI-ATHEROGENIC effect of 10% supplementation of anchovy (Engraulis encrasicolus) waste protein hydrolysates in ApoE-deficient mice
  86. Hypolipidemic and ANTI-ATHEROGENIC effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits
  87. ANTI-ATHEROGENIC effects of centipede acidic protein in rats fed an atherogenic diet
  88. In vitro Anti‐atherogenic Properties of N‐Heterocyclic Carbene Aurate (I) Compounds
  89. Phytochemical analysis of ANTI-ATHEROGENIC constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS
  90. A genome scan for loci influencing ANTI-ATHEROGENIC serum bilirubin levels
  91. Hypolipidemic and anti‐atherogenic activities of crude polysaccharides from abalone viscera
  92. Enzymatic synthesis of phytosteryl docosahexaneates and evaluation of their ANTI-ATHEROGENIC effects in apo-E deficient mice
  93. Anti-thrombotic and ANTI-ATHEROGENIC action of eicosapentaenoic acid
  94. PPAR Activity in the Vessel Wall: ANTI-ATHEROGENIC Properties
  95. … intima-media thickness by reducing small dense low-density lipoproteins in a real-world setting of patients with type 2 diabetes: A novel ANTI-ATHEROGENIC …
  96. Apoprotein AI mimetic peptides and their potential ANTI-ATHEROGENIC mechanisms of action
  97. Date (Phoenix dactylifera L.) Fruit Soluble Phenolics Composition and ANTI-ATHEROGENIC Properties in Nine Israeli Varieties
  98. Enhanced CD36 expression changes the role of Nrf2 activation from ANTI-ATHEROGENIC to pro-atherogenic in apoE-deficient mice
  99. The effect of intakes of fish and Camelina sativa oil on atherogenic and ANTI-ATHEROGENIC functions of LDL and HDL particles: A randomized controlled trial
  100. The ANTI-ATHEROGENIC effects of berberine on foam cell formation are mediated through the upregulation of sirtuin 1
  101. The endothelium as a target for ANTI-ATHEROGENIC therapy: a focus on the epigenetic enzymes EZH2 and SIRT1
  102. ANTI-ATHEROGENIC effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles
  103. Ursodeoxycholic acid (UDCA) exerts ANTI-ATHEROGENIC effects by inhibiting RAGE signaling in diabetic atherosclerosis
  104. ANTI-ATHEROGENIC actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I
  105. ANTI-ATHEROGENIC effects of vaspin on human aortic smooth muscle cell/macrophage responses and hyperlipidemic mouse plaque phenotype
  106. ANTI-ATHEROGENIC effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice
  107. Screening of ANTI-ATHEROGENIC substances from insect resources
  108. β2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the ANTI-ATHEROGENIC effect of dietary coenzyme Q10
  109. ANTI-ATHEROGENIC effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model
  110. HDL slowing down endothelial progenitor cells senescence: a novel ANTI-ATHEROGENIC property of HDL
  111. Functional interplay between liver X receptor and AMP‐activated protein kinase α inhibits atherosclerosis in apolipoprotein E‐deficient mice− a new anti‐atherogenic …
  112. Estrogen regulation of the scavenger receptor class B gene: ANTI-ATHEROGENIC or steroidogenic, is there a priority?
  113. Physicochemical characteristics of rapidly dried onion powder and its ANTI-ATHEROGENIC effect on rats fed high-fat diet
  114. Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for ANTI-ATHEROGENIC potential of taurine.
  115. The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional ANTI-ATHEROGENIC property.
  116. In vivo ANTI-ATHEROGENIC properties of cultured gilthead sea bream (Sparus aurata) polar lipid extracts in hypercholesterolaemic rabbits
  117. ANTI-ATHEROGENIC properties of vitamin E, aspirin, and their combination
  118. Hypolipidemic and ANTI-ATHEROGENIC effect of aqueous extract leaves of Ficus glumosa (Moraceae) in rats
  119. ANTI-ATHEROGENIC effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits
  120. Nicotinic acid has ANTI-ATHEROGENIC and anti-inflammatory properties on advanced atherosclerotic lesions independent of its lipid-modifying capabilities
  121. Omega–3 fatty acids, inflammation and angiogenesis: nutrigenomic effects as an explanation for ANTI-ATHEROGENIC and anti-inflammatory effects of fish and fish oils
  122. ANTI-ATHEROGENIC effects of the aqueous extract of rhubarb in rats fed an atherogenic diet
  123. Ursodeoxycholic acid (UDCA) exerts ANTI-ATHEROGENIC effects by inhibiting endoplasmic reticulum (ER) stress induced by disturbed flow
  124. ANTI-ATHEROGENIC modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study
  125. Inhibition of cytokine-induced IκB kinase activation as a mechanism contributing to the ANTI-ATHEROGENIC activity of tilianin in hyperlipidemic mice
  126. Caveolin-1 regulates the ANTI-ATHEROGENIC properties of macrophages
  127. The ANTI-ATHEROGENIC properties of HDL particles
  128. Bioactive pigments of monascus purpureus attributed to antioxidant, HMG-CoA reductase inhibition and ANTI-ATHEROGENIC functions
  129. Evaluation of in vitro antioxidant and ANTI-ATHEROGENIC properties of selected Siddha polyherbal decoctions
  130. Cell-mediated lipoprotein transport: A novel ANTI-ATHEROGENIC concept
  131. Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for ANTI-ATHEROGENIC serum bilirubin levels—the Framingham Heart Study
  132. ANTI-ATHEROGENIC effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells
  133. A novel ANTI-ATHEROGENIC role for COX-2—potential mechanism for the cardiovascular side effects of COX-2 inhibitors
  134. Anti‐atherogenic effects of high‐density lipoprotein on nitric oxide synthesis in the endothelium
  135. Mechanisms of action of the ANTI-ATHEROGENIC effect of magnesium: lessons from a mouse model.
  136. ANTI-ATHEROGENIC effects of statins: Impact on angiopoietin-2 release from endothelial cells
  137. Long term anti-diabetic, anti-hyperlipidaemic and ANTI-ATHEROGENIC effects of Carica papaya leaves in streptozotocin diabetic rats.
  138. MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport—An ANTI-ATHEROGENIC function of ERK1/2 inhibition
  139. Endothelial lipase exerts its ANTI-ATHEROGENIC effect through increased catabolism of β-VLDLs
  140. High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising ANTI-ATHEROGENIC strategy
  141. Hypolipidemic and ANTI-ATHEROGENIC effect of sulphated polysaccharides from the green alga Ulva fasciata
  142. The anti-osteoporotic and ANTI-ATHEROGENIC effects of alendronate and simvastatin in ovariectomized rats fed high fat diet: a comparative study of combination therapy …
  143. … deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro-and ANTI-ATHEROGENIC lipid profiles after 42 …
  144. The hyperlipemic hamster‐a model for testing the anti‐atherogenic effect of amlodipine
  145. ANTI-ATHEROGENIC properties of allium ursinum liophylisate: Impact on lipoprotein homeostasis and cardiac biomarkers in hypercholesterolemic rabbits
  146. Treatment with PCSK9 inhibitors induces a more ANTI-ATHEROGENIC HDL lipid profile in patients at high cardiovascular risk
  147. ANTI-ATHEROGENIC effects of 3, 4-dihydroxy hydrocinnamides
  148. The ANTI-ATHEROGENIC properties of sesamin are mediated via improved macrophage cholesterol efflux through PPARγ1-LXRα and MAPK signaling
  149. ANTI-ATHEROGENIC properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and …
  150. Glucocorticoid receptor-mediated upregulation of human CYP27A1, a potential ANTI-ATHEROGENIC enzyme
  151. Anti‐oxidative, anti‐inflammatory and anti‐atherogenic effects of Dandelion (Taraxacum officinale) extracts in C57BL/6 mice fed atherogenic diet
  152. ANTI-ATHEROGENIC effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro
  153. 14 Days of supplementation with blueberry extract shows ANTI-ATHEROGENIC properties and improves oxidative parameters in hypercholesterolemic rats model
  154. The ANTI-ATHEROGENIC potential of serum amyloid A peptides.
  155. Effect of N‐(p‐coumaroyl)serotonin and N‐feruloylserotonin, major anti‐atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of …
  156. Genistein as a potential inducer of the anti‐atherogenic enzyme paraoxonase‐1: studies in cultured hepatocytes in vitro and in rat liver in vivo
  157. ANTI-ATHEROGENIC effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice
  158. ANTI-ATHEROGENIC effect of San-Huang-Xie-Xin-Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells
  159. ANTI-ATHEROGENIC properties of Deglet Noor date seeds (Phoenix dactylifera) methanol extract on diet-induced hypercholesterolemic rats
  160. Sphingosine kinase inhibition exerts both pro-and ANTI-ATHEROGENIC effects in low-density lipoprotein receptor-deficient (LDL-R−/−) mice
  161. Apolipoprotein ε2 allele is associated with an ANTI-ATHEROGENIC lipoprotein profile in children: the Columbia University BioMarkers Study
  162. … endothelial production of heparan sulfate rich in biologically active heparin-like domains: a potential mechanism for the ANTI-ATHEROGENIC actions of vascular …
  163. Endothelium-dependent hyperpolarization as a remote ANTI-ATHEROGENIC mechanism
  164. ANTI-ATHEROGENIC effects of the acyl-CoA: cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages
  165. ANTI-ATHEROGENIC effect of Humulus japonicus in apolipoprotein E-deficient mice
  166. Ginkgo biloba extract (GbE) enhances the ANTI-ATHEROGENIC effect of cilostazol by inhibiting ROS generation
  167. ANTI-ATHEROGENIC antioxidants regulate the expression and function of proteasome α-type subunits in human endothelial cells
  168. Probucol and cilostazol exert a combinatorial ANTI-ATHEROGENIC effect in cholesterol-fed rabbits
  169. Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential ANTI-ATHEROGENIC properties
  170. Evaluation of nicotinic acid as an hypocholesteremic and ANTI-ATHEROGENIC substance
  171. Cell culture as a testing system for ANTI-ATHEROGENIC substances: a brief communication
  172. Scavenger receptor B-1 emerges as ANTI-ATHEROGENIC candidate
  173. Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces ANTI-ATHEROGENIC effects on cardiovascular risk biomarkers in HIV-infected and …
  174. Efficient coexpression and secretion of ANTI-ATHEROGENIC human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno …
  175. Antithrombic and ANTI-ATHEROGENIC effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein …
  176. C-terminal apolipoprotein E-derived peptide, Ep1. B, displays ANTI-ATHEROGENIC activity
  177. The ANTI-ATHEROGENIC cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1,-4 and-5 in human …
  178. Statins but not fibrates improve the atherogenic to ANTI-ATHEROGENIC lipoprotein particle ratio: a randomized crossover study
  179. Evaluation of the in vitro ANTI-ATHEROGENIC properties of lipid fractions of olive pomace, olive pomace enriched fish feed and gilthead sea bream (Sparus aurata) fed …
  180. 20 (S)-protopanaxadiol saponins mainly contribute to the ANTI-ATHEROGENIC effects of Panax notoginseng in ApoE deficient mice
  181. ANTI-ATHEROGENIC and anti-ischemic potentials of Croton membranaceus observed during sub-chronic toxicity studies
  182. Evaluation of the ANTI-ATHEROGENIC potential of Egyptian artichoke leaf extract in hypercholesterolemic rats
  183. ANTI-ATHEROGENIC effects of a new thienylacylhydrazone derivative, LASSBio-788, in rats fed a hypercholesterolemic diet
  184. … of a disintegrin and metalloproteinase with thrombospondin motifs 4 in human macrophages is inhibited by the ANTI-ATHEROGENIC cytokine transforming growth …
  185. The ANTI-ATHEROGENIC aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory …
  186. APOA-1Milano muteins, orally delivered via genetically modified rice, show ANTI-ATHEROGENIC and anti-inflammatory properties in vitro and in Apoe …
  187. Comparison of cholesterol-lowering efficacy and ANTI-ATHEROGENIC properties of hydrogenated versus non-hydrogenated (Phytrol™) tall oil-derived phytosterols in apo …
  188. ANTI-ATHEROGENIC effect of isoflavone through hypolipidemic, anti-oxidative and anti-inflammatory actions in C57BL/6 mice
  189. Androgen receptor-mediated regulation of the ANTI-ATHEROGENIC enzyme CYP27A1 involves the JNK/c-jun pathway
  190. Human plasma paraoxonase (HuPON1): an ANTI-ATHEROGENIC enzyme with organophosphate hydrolase activity
  191. Betulinic acid and fluvastatin exhibits synergistic effect on toll-like receptor-4 mediated ANTI-ATHEROGENIC mechanism in type II collagen induced arthritis
  192. The ANTI-ATHEROGENIC effects of lycopene
  193. The anti-hyperlipemic and ANTI-ATHEROGENIC effect of” essential” phospholipids: a pharmacologic trial
  194. Testing of ANTI-ATHEROGENIC drugs and food components on cell cultures: assessment of reliability
  195. Protamine may have ANTI-ATHEROGENIC potential by inhibiting the binding of oxidized-low density lipoprotein to LOX-1
  196. ANTI-ATHEROGENIC properties of Kgengwe (Citrullus lanatus) seed powder in low-density lipoprotein receptor knockout mice are mediated through beneficial alterations …
  197. The ANTI-ATHEROGENIC effect of dietary soybean protein concentrate in hamsters
  198. Structure and lipid interactions of an anti-inflammatory and ANTI-ATHEROGENIC 10-residue class G⁎ apolipoprotein J peptide using solution NMR
  199. Multiple pathway assessment to predict ANTI-ATHEROGENIC efficacy of drugs targeting macrophages in atherosclerotic plaques
  200. ANTI-ATHEROGENIC properties of emulsified perilla oil (EPO) in apo E KO mice and plasma lipid lowering effects of rice porridge containing EPO in healthy young adults
  201. ANTI-ATHEROGENIC effect of Nepitrin-7-O-glucoside: A flavonoid isolated from Nepeta hindostana via acting on PPAR–α receptor
  202. ANTI-ATHEROGENIC effects of curcumin in hypercholesterolemic rabbits
  203. Anti-thrombotic and ANTI-ATHEROGENIC action of eicosapentaenoic acid
  204. Antihypercholesterolemic and ANTI-ATHEROGENIC effects of lyophilized aqueous extract of Globularia alypum leaves in rats fed a high-cholesterol diet
  205. Inhibition of plasma lipid peroxidation by ANTI-ATHEROGENIC antioxidant BO-653, 2, 3-dihydro-5-hydroxy-4, 6-di-tert-butyl-2, 2-dipentylbenzofuran
  206. Antioxidant and ANTI-ATHEROGENIC Properties of Prosopis strombulifera and Tessaria absinthioides Aqueous Extracts: Modulation of NADPH Oxidase-Derived …
  207. On the ANTI-ATHEROGENIC effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions
  208. Hypolipidemic and ANTI-ATHEROGENIC Activity of Aqueous Extract of Leaves of Lagenaria siceraria in Wistar Rats
  209. ANTI-ATHEROGENIC effects of high density lipoproteins: Mechanisms
  210. Ritonavir exhibits ANTI-ATHEROGENIC properties on vascular smooth muscle cells
  211. Hypocholesterolaemic and ANTI-ATHEROGENIC Effects of Palm-Based Oils (NoveLin I and NoveLin II) in Cholesterol-Fed Rabbits
  212. ANTI-ATHEROGENIC effects of resveratrol via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages
  213. ANTI-ATHEROGENIC effects of an egg yolk-enriched garlic supplement
  214. The ANTI-ATHEROGENIC effects of thiazolidinediones
  215. High density lipoproteins: the ANTI-ATHEROGENIC fraction
  216. Biochemical mechanism of insulin sensitization, lipid modulation and ANTI-ATHEROGENIC potential of PPAR α/γ dual agonist: Ragaglitazar
  217. ANTI-ATHEROGENIC Effects of a Phenol-Rich Fraction from Brazilian Red Wine (Vitis labrusca L.) in Hypercholesterolemic Low-Density Lipoprotein Receptor Knockout …
  218. … infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the ANTI-ATHEROGENIC effects of losartan
  219. Inhibition of LDL oxidation and inflammasome assembly by nitroaliphatic derivatives. Potential use as anti-inflammatory and ANTI-ATHEROGENIC agents
  220. Significant deterioration of ANTI-ATHEROGENIC efficacy of nebivolol in a double (apolipoprotein E and endothelial nitric oxide synthase) knockout mouse model of …
  221. Are calcium ion antagonists effective ANTI-ATHEROGENIC agents?
  222. ANTI-ATHEROGENIC action of Panax ginseng in rats and in patients with hyperlipidemia
  223. Incretins in type 2 diabetes mellitus: cardiovascular and ANTI-ATHEROGENIC effects beyond glucose lowering
  224. The ANTI-ATHEROGENIC activity of beauveriolide derivative BVD327, a sterol O-acyltransferase 2-selective inhibitor, in apolipoprotein e knockout mice
  225. ANTI-ATHEROGENIC effects of fermented fresh coffee bean, soybean and rice bran extracts
  226. Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent ANTI-ATHEROGENIC agents in vivo
  227. The C17-OH Group of Œstradiol: Relationships between its ANTI-ATHEROGENIC and Endocrine Actions
  228. ANTI-ATHEROGENIC effects of phytosteryl oleates in apo-E deficient mice
  229. ANTI-ATHEROGENIC peptide Ep1. B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells
  230. Potential ANTI-ATHEROGENIC cell action of the naturally occurring 4-O-methyl derivative of gallic acid on Ang II-treated macrophages
  231. The pro-inflammatory effect of uraemia overrules the ANTI-ATHEROGENIC potential of immunization with oxidized LDL in apoE−/− mice
  232. ANTI-ATHEROGENIC effects of fibrates in type 2 diabetes
  233. Folate and vitamin B12 in morbid obesity: the influence of folate on ANTI-ATHEROGENIC lipid profile
  234. ANTI-ATHEROGENIC properties of fibrates may be largely due to their anti-inflammatory effects
  235. Atherogenic and ANTI-ATHEROGENIC plasma lipoproteins modulate secretion of prostanoids by endothelial cells in vitro
  236. Different functional and structural characteristics between ApoA-I and ApoA-4 in lipid-free and reconstituted HDL state: ApoA-4 showed less ANTI-ATHEROGENIC …
  237. ANTI-ATHEROGENIC effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice
  238. ANTI-ATHEROGENIC Role of Peroxisome Proliferator-Activated Receptor Ligands
  239. Anti–Atherogenic Activity of Ethanol Extract of Buccholzia coriacea Seeds on Hypercholesterolemic Rats.
  240. Cholesterol-lowering and ANTI-ATHEROGENIC effects of oats in mice
  241. Lack of difference among progestins on the anti‐atherogenic effect of ethinyl estradiol: a rabbit study
  242. Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and ANTI-ATHEROGENIC treatment in insulin resistant type 2 diabetes …
  243. The beneficial effects of high-density lipoprotein on adipocytes may relate to its ANTI-ATHEROGENIC properties
  244. The ANTI-ATHEROGENIC mechanism of action of physical training in patients with coronary heart disease
  245. Adiponectin-a novel ANTI-ATHEROGENIC factor in the metabolic syndrome: mechanisms of action and therapeutic potential
  246. ANTI-ATHEROGENIC properties of extra virgin olive Oil
  247. Observation of Inflammatory Marker Levels in Sprague-Dawley Rats with Youngyopaedoc-san-related ANTI-ATHEROGENIC Effect
  248. Inhibition of LDL oxidation and oxidized LDL-induced foam cell formation in RAW 264.7 cells show ANTI-ATHEROGENIC properties of a foliar methanol extract of …
  249. Inhibition Effect of 3-(4′-hydroxyl-3′,5′-dimethoxyphenyl)Propionic Acid in Kimchi with ANTI-ATHEROGENIC Activity on the Accumulation of Lipids in the Organs of ApoE(-/-) …
  250. HO-1, a new target of PPARδ with ‘ANTI-ATHEROGENIC‘properties: is it the one?
  251. ANTI-ATHEROGENIC effect and its mechanisms of soluble egg antigen of schistosomia japonicum in ApoE-/-mice
  252. … in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and ANTI-ATHEROGENIC properties of this …
  253. Additive ANTI-ATHEROGENIC effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice
  254. Interleukin-11: a neglected cytokine with ANTI-ATHEROGENIC properties?
  255. Mouse models of experimental atherosclerosis as a tool for checking a putative ANTI-ATHEROGENIC action of drugs
  256. Hypolipidemic and ANTI-ATHEROGENIC effects of vanadium in high-fat diet rabbits.
  257. … E knockout mice: an experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative ANTI-ATHEROGENIC properties of drugs
  258. Anti‐inflammatory and anti‐atherogenic effects of adiponectin in patients with rheumatoid arthritis following anti‐TNF therapy
  259. Characteristics of the lipid composition of atherogenic and ANTI-ATHEROGENIC serum lipoproteins in patients with bronchial asthma
  260. The ANTI-ATHEROGENIC role of exercise is associated with the attenuation of bone marrow-derived macrophage activation and migration in hypercholesterolemic …
  261. Sardine purified proteins improve blood pressure, glycemic control, ANTI-ATHEROGENIC metabolic pathways and antioxidant capacity in obese rats
  262. Does ANTI-ATHEROGENIC estradiol valerate treatment cause adverse effects on liver and uterus in NZW rabbits?
  263. Cross-talk between exogenous statins and endogenous high-density lipoprotein in anti-inflammatory and ANTI-ATHEROGENIC actions
  264. The ANTI-ATHEROGENIC Activity of Artemisia, Thyme & Soya bean
  265. P58 Potential ANTI-ATHEROGENIC effects of hydrogen-sulfide releasing molecules
  266. ANTI-ATHEROGENIC effect of Ca2+-antagonists
  267. Ezetimibe–new anti‐atherogenic properties?
  268. Pre-clinical evaluation of the hypotensive and ANTI ATHEROGENIC activity of hydroethanolic extract of Eribroma oblongum (Malvaceae) stem bark on wistar rats models
  269. The Effects of ANTI-ATHEROGENIC Properties of Beverage of the Date Seeds (Phoenix Dactilifera L.) In Pre-Menopause Women: A Study Of Indonesian Women
  270. ANTI-ATHEROGENIC Action of “Cardipro”-A Herbal Proprietary Formulation
  271. … (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and ANTI-ATHEROGENIC effects.
  272. Lactobacillus fermentum ME-3–a probiotic with potential for ANTI-ATHEROGENIC, anti-oxidative and anti-diabetic application
  273. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced ANTI-ATHEROGENIC effects
  274. The adenosine A2A receptor agonist UK-432,097 stimulates expression of ANTI-ATHEROGENIC reverse cholesterol transport proteins
  275. Metabolic and ANTI-ATHEROGENIC effects of long-term benfluorex in dyslipidemic insulin-resistant sand rats (Psammomys obesus)
  276. ANTI-ATHEROGENIC effects of supplementation with vitamin B6 (Pyridoxine) in albino rats
  277. The ANTI-ATHEROGENIC effects of eicosapentaenoic and docosahexaenoic acid are dependent on the stage of THP-1 macrophage differentiation
  278. ANTI-ATHEROGENIC properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy
  279. ANTI-ATHEROGENIC activity of wild grape (Vitis thunbergii) extract antagonizing smooth muscle cell proliferation and migration promoted by neighboring macrophages
  280. The role of 15-lipoxygenase in atherogenesis. Pro-and/or ANTI-ATHEROGENIC action
  281. ANTI-ATHEROGENIC drugs
  282. Comparative ANTI-ATHEROGENIC Effects of a Single Intravenous Injection of rAAV8 Or rAAV2 Encoding Apo A-IMilano Gene
  283. Anti-inflammatory and ANTI-ATHEROGENIC role of BMP receptor II in atherosclerosis
  284. ANTI-ATHEROGENIC effect of green tea product through hypolipidemic and anti-oxidative action in ovariectomized rats
  285. Immunomodulatory activity of ANTI-ATHEROGENIC drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune …
  286. How to use ezetimibe as an ANTI-ATHEROGENIC agent via inhibition of rho-Kinase
  287. Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated ANTI-ATHEROGENIC …
  288. Multi-functional aspects of high density lipoprotein as an ANTI-ATHEROGENIC lipoprotein in vivo: evidence from in vitro experiments using macrophages
  289. ANTI-ATHEROGENIC effects of cryopreserved preparation of fetoplacental complex in experimental atherosclerosis
  290. Re-Programming Atherosclerotic Plaque Macrophages Towards An ANTI-ATHEROGENIC Phenotype
  291. P5330 Evaluating lipid-lowering and ANTI-ATHEROGENIC effect of injectable Curcumin in a rabbit model of atherosclerosis
  292. Mechanisms of ANTI-ATHEROGENIC action of probucol
  293. Concurrent training promoted sustained ANTI-ATHEROGENIC benefits in the fasting plasma triacylglycerolemia of postmenopausal women at 1-year follow-up
  294. Possible ANTI-ATHEROGENIC effects of emodin, an anthraquinone from Chinese herbs and Aspergillus and Penicillium fungi.
  295. Approaches for the Design of Novel ANTI-ATHEROGENIC Compounds
  296. Anti‐Atherogenic Effects of Lesion‐Targeted Epigallocatechin Gallate (EGCG)‐Loaded Nanoparticles
  297. Antioxidant and ANTI-ATHEROGENIC Properties of Hawthorn Vinegar in Drosophila melanogaster Fed a High-Fat Diet.
  298. Methotrexate improves pro-and ANTI-ATHEROGENIC genomic expression in psoriatic skin
  299. Anti‐Atherogenic Potential of Edible Mushrooms
  300. Comparative study of hydrochlorothiazide and indapamide on the ANTI-ATHEROGENIC potential of losartan in cholesterol fed rat
  301. ANTI-ATHEROGENIC Effect of Green Tea
  302. ANTI-ATHEROGENIC FUNCTIONS OF HIGH DENSITY LIPOPROTEINS
  303. Effect of Aqueous Seed Extract of Carica Papaya on Lipid Profile and Anti‐Atherogenic Index of Wistar Rat Following Cholesterol Administration
  304. Evaluation of ANTI-ATHEROGENIC properties of ezetimibe using 3H-labeled LDL and 99mTc-cAbVCAM1-5 SPECT imaging in ApoE-/-mice fed a paigen diet
  305. Lecithin cholesterol acyltransferase: an anti-or pro-atherogenic factor?
  306. Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids
  307. Antioxidant and cholesterol lowering properties of 2, 6-di-t-butyl-4-[(dimethylphenylsilyl) methyloxy] phenol and derivatives: a new class of ANTI-ATHEROGENIC …
  308. Cholesteryl Ester Transfer Protein Genotype Predicts ANTI-ATHEROGENIC Lipid Profile and Decreased Risk of Ishemic Heart Disease, Ischemic Cerebrovascular Disease …
  309. eNOS-NO system contributes to a novel ANTI-ATHEROGENIC effect of Leonurine via inflammation inhibition and plaque stabilization
  310. Effect of an ANTI-ATHEROGENIC diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension …
  311. Intervention with anti-inflammatory RVE1 attenuates atherosclerosis without decreasing plasma cholesterol and adds to the ANTI-ATHEROGENIC effect of atorvastatin
  312. ANTI-ATHEROGENIC effect of NIP-200 on the experimental atherosclerosis in cholesterol-fed rabbits
  313. ANTI-ATHEROGENIC actions of (+)-catechin
  314. 0383: anti-inflammatory and ANTI-ATHEROGENIC effects of the inflammasome NLRP3 inhibitor, arglabin, in ApoE2Ki mice fed a high fat diet
  315. Chemical Composition, Anti-neuraminidase, and ANTI-ATHEROGENIC Activities of the Essential Oil from two Varieties of Alpinia zerumbet Leaves
  316. Endothelial lipase exerts its ANTI-ATHEROGENIC effect through increased catabolism of β-VLDLS
  317. Insulin-like growth factor-1 upregulates junction proteins in vascular endothelial cells: potential mechanisms for ANTI-ATHEROGENIC effect of insulin-like growth factor-1
  318. ANTI-ATHEROGENIC Effect of Oleanolic Acid Appears Unrelated to Endothelial Release of Nitric Oxide
  319. A new anti‐atherogenic strategy
  320. ANTI-ATHEROGENIC actions of dihomo-gamma-linolenic acid in macrophages
  321. Pioglitazone treatment may lead to ANTI-ATHEROGENIC alterations of lipoproteins through increasing serum adiponectin in statin-treated diabetes patients
  322. ANTI-ATHEROGENIC Action of Eicosapentaenoic Acid
  323. Loss of macrophage LDL receptor related protein 1 (LRP1) confers resistance to the ANTI-ATHEROGENIC effects of TNFα inhibition
  324. ANTI-ATHEROGENIC Diets: Observations from Mouse Models
  325. Adoptive Cell Transfer Demonstrates that CD8+ T cells Mediate the ANTI-ATHEROGENIC Effects of the ApoB-100 Peptide P210 Immunization in ApoE−/− Mice
  326. ADENOVIRAL EXPRESSION OF HUMAN LCAT IN NON-HUMAN PRIMATES LEADS TO AN ANTI-ATHEROGENIC LIPOPROTEIN PHENOTYPE BY …
  327. Disturbed Flow-Targeting Nanovesicles for ANTI-ATHEROGENIC Theragnosis
  328. ANTI-ATHEROGENIC effects of resveratrol via liver X receptor a-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages
  329. Anti-inflammatory and ANTI-ATHEROGENIC Effects of Lactobacillus plantarum in Hypercholesterolemic Mice
  330. ANTI-ATHEROGENIC actions of dihomo-gamma-linolenic acid and its key metabolites
  331. Sphingosine 1-phosphate (S1P) receptor type 1 signaling induces an ANTI-ATHEROGENIC phenotype in macrophages and attenuates atherosclerosis in LDL-receptor …
  332. Involvement of Vascular Endothelial Cells in the ANTI-ATHEROGENIC Effects of Liraglutide in Diabetic Apolipoprotein E-null Mice
  333. Anti-inflammatory, antioxidative and ANTI-ATHEROGENIC bioactivity in marine sources ascribed to nonlipid constituents
  334. The role of the ERK1: STAT1 serine 727 phosphorylation axis on key atherosclerosis associated cellular processes and the ANTI-ATHEROGENIC actions of hydroxytyrosol
  335. Fish and camelina sativa oil: effects on fatty acid composition of blood lipid fractions, lipoprotein subclasses and pro-and ANTI-ATHEROGENIC lipoprotein functions
  336. Antihypercholesterolemic, antioxidative and anti-inflammatory potential of an extract of the plant Tabernaemontana divaricata in experimental rats fed an atherogenic …
  337. ANTI ATHEROGENIC Effects of Micro RNA-21
  338. Ateronon: First clinically proven ANTI-ATHEROGENIC antioxidant
  339. Atherogenic and ANTI-ATHEROGENIC risk markers in subjects with obesity and/or type 2 diabetes
  340. ANTI-ATHEROGENIC Effect of Nuts: Is the Answer NO?-Reply
  341. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents
  342. THE ANTI-INFLAMMATORY AND POTENTIAL ANTI-ATHEROGENIC EFFECT OF INSULIN
  343. Vascular endothelial expression of atherogenic and ANTI-ATHEROGENIC proteins in humans: Relations to cardiovascular disease risk factors
  344. Anti-inflammatory and ANTI-ATHEROGENIC role of IL-32α in vascular endothelium
  345. Plasma level of atherogenic and ANTI-ATHEROGENIC factors among palm wine drinkers of rural Southwest Nigeria
  346. Application of the cDNA array system for screening ANTI-ATHEROGENIC agents
  347. Testing of anti‐atherogenic drugs on cell cultures: reliability questioned
  348. Evaluation of ANTI-ATHEROGENIC effects of P2Y12 receptor antagonists in Apolipoprotein E-deficient mice
  349. In vivo antioxidant action and ANTI-ATHEROGENIC effect of a novel antioxidant (BO-653)
  350. ANTI-ATHEROGENIC properties of HDL: Insights from the AIMilano mutation
  351. IgM autoantibodies against lipoprotein (A) as an “ANTI-ATHEROGENIC” factor in patients with severe hyperlipidemia
  352. Abstract# 2703: Anti-carcinogenic and ANTI-ATHEROGENIC potential of dietary phytochemicals
  353. ANTI-ATHEROGENIC Properties of Heme Oxygenase
  354. Anti‐atherogenic Effect of T0901317 Nanovesicles in THP‐1 Derived Macrophages
  355. Mountain tea (Sideritis plants): A potential ANTI-ATHEROGENIC agent?
  356. Erratum to: Cell Culture as a Testing System for ANTI-ATHEROGENIC Substances: A Brief Communication
  357. PROGNOSTIC IMPLICATIONS OF ATHEROGENIC/ANTI-ATHEROGENIC LIPID RATIOS IN AN ETHNICALLY DIVERSE POPULATION.
  358. OP22 The impact of estrogen on the ANTI-ATHEROGENIC effect of H2S
  359. MECHANISMS OF ACTION OF PHENOLIC COMPOUNDS FOCUSES ON THEIR ANTI-OXIDATIVE AND ANTI-ATHEROGENIC EFFECTS
  360. ANTI-ATHEROGENIC Effects of Cureumin in Hypercholesterolemic Rabbits
  361. ANTI-ATHEROGENIC effects of dietary supplementation of Kgengwe (Citrullus lanatus) seed powder in low density lipoprotein receptor knock-out mice
  362. Identification of ANTI-ATHEROGENIC and Anti-inflammatory Effects of Walnuts and Pistachios
  363. Effect of heating on the ANTI-ATHEROGENIC action of sunflower oil.
  364. Anti-inflammatory and ANTI-ATHEROGENIC effects of 9E,11E-conjugated linoleic acid
  365. Rosemary as ANTI-ATHEROGENIC food ingredient
  366. ANTI-ATHEROGENIC mechanisms of berberine
  367. Long term hypolipidaemic and ANTI-ATHEROGENIC effects ofCarica papaya Linn. administration on normal rabbits
  368. Anti‐atherogenic effect of blue‐green algae in male apolipoprotein E knockout mice fed an atherogenic diet
  369. Novel ANTI-ATHEROGENIC effects of MH13 in vascular smooth muscle cells
  370. Study on Effects of Food Factors and ANTI-ATHEROGENIC Lipoprotein Function (Young Investigator Award of JSFNS (2013))
  371. Lipoprotein interactions with the arterial wall: Pro-vs. ANTI-ATHEROGENIC effects
  372. Therapeutic strategies in management of atherosclerosis by manipulation of ANTI-ATHEROGENIC B1a lymphocytes
  373. ANTI-ATHEROGENIC effect of circylating immune complexes in schistosomal hepatic fibrosis
  374. Anti‐atherogenic effect of dandelion extracts through anti‐inflammatory and anti‐oxidative processes in C57BL/6 mice
  375. ANTI-ATHEROGENIC potential of γ-linolenic acid.
  376. ANTI-ATHEROGENIC effect of calcium antagonist plus statin cotreatment realises at lipoprotein level
  377. ANTI-ATHEROGENIC effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase 2 independent mechanisms 3
  378. Different association of serum docosahexaenoic acid and eicosapentaenoic acid levels with atherogenic and ANTI-ATHEROGENIC lipoproteins in statin-treated diabetes …
  379. Physicochemical characteristics of rapidly dried onion powder and its ANTI-ATHEROGENIC effect
  380. A Study of Antiobesity, Hypolipidemic and ANTI-ATHEROGENIC Activity of Poly Herbal Formulation against High Fat Diet-Induced Obesity in Albino Rats
  381. ANTI-ATHEROGENIC Effects of the Methanol Extract of Sorbus Cortex in Atherogenic-Diet Rats (Pharmacognosy)
  382. Comparison of the ANTI-ATHEROGENIC and Anti-metabolic Effects Between Miglitol and Nteglinide in Diabetic Patients with Coronary Artery Disease
  383. Thromboxane receptor blockade improves the ANTI-ATHEROGENIC effect of
  384. ANTI-ATHEROGENIC, Anti-Inflammatory, and Anti-Hypertensive Effects of Peanuts Determined with In Vivo and In Vitro Models
  385. ANTI-ATHEROGENIC effect of enterosorption in patients with diabetes mellitus
  386. The ANTI-ATHEROGENIC Activity of Luteolin and Luteolin-7-O-glucoside in High-Fat Diet-Administered Hyperhomocysteinemia-Induced C57BL/6J Mice
  387. Novel pro-and ANTI-ATHEROGENIC effects of apolipoprotein B-containing lipoproteins: To feast or to fast?
  388. ANTI-ATHEROGENIC effect of circulating immune complexes in schistosomal hepatic fibrosis
  389. Fish oil supplementation induces ANTI-ATHEROGENIC gene expression profiles in human blood mononuclear cells
  390. Anti-Inflammatory and ANTI-ATHEROGENIC Activities of Ncx 6560, a Nitric Oxide (no)-Donating Statin, in Hypercholesterolemic Mice
  391. ANTI-ATHEROGENIC Effects of Functional Sujeonggwa Drinks in Hypercholesterolemic Apo E KO Mice
  392. ANTI-ATHEROGENIC AND ANTI-ANGIOGENIC EFFECTS OF DONEPEZIL, A DRUG FOR ALZHEIMER’S DISEASE
  393. Analysis of the Molecular Organization of Lipoprotein-Associated Apolipoprotein E, an ANTI-ATHEROGENIC Protein
  394. CYP1A1 and CYP1B1 expression and free zinc levels in endothelial cells are differentially regulated by pro-atherogenic versus ANTI-ATHEROGENIC shear stress
  395. Studies on the Pathogenesis of Atherosclerosis and Development of ANTI-ATHEROGENIC Small Molecule Using Gene Targeted Mouse
  396. Hypolipidemic and anti‐atherogenic effect of omega‐3 enriched structured lipids from linseed oil (LSO) with refined palm olein oil (RPOO) on rats fed atherogenic diet
  397. Platycodin D lowers cholesterol in vivo and has ANTI-ATHEROGENIC properties in vitro
  398. Apolipoprotein B Bound To Erythrocytes: A Novel ANTI-ATHEROGENIC Lipid Transport Pathway
  399. < The> metabolic effect of partial lipectomy in old aged rats and the associated changes in the ANTI-ATHEROGENIC index: adiponectin/leptin ratio
  400. ANTI-ATHEROGENIC function of LPL in human and porcine coronary endothelial cells
  401. Comparison the ANTI-ATHEROGENIC and hypolipidaemic effect of Cod liver oil, pomegranate seed oil and Rosuvastatin in hyperecholestrolemic rats
  402. Pro-and ANTI-ATHEROGENIC effects of a dominant negative P465L mutation of PPARγ in apolipoprotein E-null mice
  403. ANTI-ATHEROGENIC Effect of Novel Peroxisome Proliferator-Activated Receptor δ Agonist RSC-451061 Hydrochloride Accompanied by Anti-Inflammatory Effects in LDL …
  404. Statin treatment potentiates the lipid-lowering and ANTI-ATHEROGENIC effect of bat activation by accelerating lipoprotein remnant clearance
  405. HDL and ABC Transporters Reduce the Proliferation of Hematopoietic Stem and Progenitor Cells, with ANTI-ATHEROGENIC Consequences
  406. ANTI-ATHEROGENIC properties of paraoxonase 2 and paraoxonase 3: In vitro and in vivo studies
  407. Kruppel-like factors: emerging regulators mediating the ANTI-ATHEROGENIC effects of flow shear stress
  408. FENOFIBRATE-MEDIATED ANTI-ATHEROGENIC ACTIVITY: LONG-TERM FOLLOW-UP STUDY OF RHEUMATOID ARTHRITIS PATIENTS BY COMPARING …
  409. 11: THE ADENOSINE A2A RECEPTOR AGONIST UK-432,097 STIMULATES ANTI-ATHEROGENIC REVERSE CHOLESTEROL TRANSPORT PROTEINS IN THP-1 …
  410. The Role of Scavenger Receptor-A in Heat Shock Protein 27-mediated Atheroprotection: Mechanistic Insights into a Novel ANTI-ATHEROGENIC Therapy
  411. Novel anti‐atherogenic effects of trivalent chromium in vascular smooth muscle cells: therapeutic implication for diabetic vascular complications
  412. Schistosoma Mansoni infection induces ANTI-ATHEROGENIC transcriptional changes in hepatic macrophages (MPF2P. 758)
  413. Nanoencapsulation Enhances Epigallocatechin Gallate (EGCG) Stability and Its ANTI-ATHEROGENIC Bioactivities in Macrophages
  414. 66-mercaptopurine induces ANTI-ATHEROGENIC effects in monocytes/macrophages and inhibits
  415. eNOS-NO system attributes to novel ANTI-ATHEROGENIC effect of leonurine via inflammation inhibition and plaque stabilization
  416. ANTI-ATHEROGENIC and Nephroprotective Effects of Tocotrienol Rich Fraction (TRF) from Palm Oil and Rice Bran Oil
  417. ANTI-ATHEROGENIC effects of long term benfluorex treatment in insulino-resistant Sand rats (Psammomys obesus)
  418. ANTI-ATHEROGENIC Effects of Hexane Extracts of Yam, Dioscorea batatas Decne
  419. In vitro radical scavenging activity of short arm octopus added kimchi and its ANTI-ATHEROGENIC effects in Apo E KO mice
  420. ANTI-ATHEROGENIC AND ANTIOXIDANT POTENCY OF TINOSPORA CRISPA IN RABBITS FED WITH HIGH FAT DIET.
  421. Change of natural antibody levels in patients with cardiovascular diseases by the use of ANTI-ATHEROGENIC diets with processed soy product foods
  422. Inhibition of Cytokine Induced I-B Kinase Activation as a Mechanism Contributing to the ANTI-ATHEROGENIC Activity of Tilianin in Hyperlipidemic Mice
  423. The effect of antibodies against high-density lipoprotein (aHDL) and apolipoprotein AI (aApo AI) on the ANTI-ATHEROGENIC and anti-inflammatory properties of HDL in …
  424. Niacin improves ANTI-ATHEROGENIC effect of statins in APOE* 3Leiden. CETP mice
  425. Functional interplay between LXR and AMPK inhibits atherosclerosis in apoE deficient mice——A new ANTI-ATHEROGENIC strategy
  426. Assessment of ANTI-ATHEROGENIC drugs in vivo and reconstitution of lipoproteins using radioiodinated cholesteryl iopanoate
  427. Beyond LDL Cholesterol: Carriers of the PCSK9 R46L Variant Are Characterized by an ANTI-ATHEROGENIC Lipoprotein Profile Assessed by Nuclear Magnetic …
  428. Viral ANTI-ATHEROGENIC Proteins Alter Monocyte and Neutrophil Invasion in Mice and Bag3 Gene Expression
  429. Bone Marrow Angiotensin AT2 Receptor Deficiency Aggravates Atherosclerosis by Eliminating Macrophage Liver X Receptor-Mediated ANTI-ATHEROGENIC Actions
  430. Opuntiol and opuntioside-I an ANTI-ATHEROGENIC agent interfering with chemotaxis via IPLA2B-dependent F-actin polymerization in human monocyte
  431. Molecular Pathology: Poster# 247 OPUNTIOL AND OPUNTIOSIDE-I AN ANTI-ATHEROGENIC AGENT INTERFERING WITH CHEMOTAXIS VIA IPLA2B-DEPENDENT …
  432. English walnut (Juglans regia) and human immune function: Support of the ANTI-ATHEROGENIC properties of walnuts and identification of a new link in …
  433. Combination Therapy with Olmesartan and Azelnidipine Exerts ANTI-ATHEROGENIC Effects in Diabetic Apolipoprotein E-Deficient Mice
  434. VIRAL ANTI-ATHEROGENIC PROTEINS ALTER MONOCYTE AND NEUTROPHIL INVASION IN MICE WITH ALTERED BAG3 GENE EXPRESSION
  435. Resveratrol Protects against Atherosclerosis, but Does not Add to the ANTI-ATHEROGENIC Effect of Atorvastatin, in APOE* 3-Leiden. CETP Mice
  436. Cilostazol Selectively Increases ANTI-ATHEROGENIC HDL Subclass (LpA-I particles) in Male Patients with Non-insulin Dependent Diabetes Mellitus
  437. … of Differentially Expressed Genes in the Aortae of Apoe-deficient Mice Infused with Insulin-like Growth Factor I: Novel Mechanisms of the ANTI-ATHEROGENIC Effect of IGF …
  438. Supplementary Material to Conditional linkage and genome-wide association studies identify UGT1A1 as major gene for ANTI-ATHEROGENIC serum bilirubin levels–a …
  439. ANTI-ATHEROGENIC properties associated with the antioxidant activity from the hydrophilic extracts of Halimeda incrassata (Chlorophyta, Bryopsidales)
  440. The anti‐atherogenic potential of C‐type natriuretic peptide: Disparate regulation of endothelial and vascular smooth muscle cell proliferation via natriuretic peptide …
  441. Apolipoprotein J (clusterin) induces cholesterol export from macrophage foam cells: A potential ANTI-ATHEROGENIC function?
  442. … T Lymphocytes Recruitment by Inhibiting T Lymphocytotropic CXC Chemokines in LPS-Stimulated Macrophages: A Potential ANTI-ATHEROGENIC Function of Adiponectin
  443. Attenuated ANTI-ATHEROGENIC Effects by Statins in Diabetic Patients in Comparison with Non-diabetic Patients; Non-invasive Quantitative Analysis of Coronary …
  444. Is the Post-menopausal Rise in PCSK9 Levels Due to Loss of the Estrogen Responsive ANTI-ATHEROGENIC Protein, Heat Shock Protein 27? Insights Into a Potential New …
  445. Circulating Markers Reflect Both Anti-and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice
  446. Immunomodulatory and anti-angiogenic properties of Linum usitatissium (flaxseed) seeds ethanolic extract in atherogenic diet treated rats
  447. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction
  448. Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE* 3Leiden. CETP mice
  449. ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein (a); anti-vs. pro-atherogenic properties
  450. Anti-obesity potential of almond (Prunus dulcis) in experimental animals under cafeteria and atherogenic diets
  451. Malvidin 3-glucoside, a dietary anthocyanin, contributes to the balance between pro-and anti-inflammatory mediators in human endothelial cells: a potential role …

Related Posts

Shopping Cart
Scroll to Top